A cost effective analysis of fixed-dose combination of dutasteride and tamsulosin compared with dutasteride monotherapy for benign prostatic hyperplasia in Nigeria: a middle income perspective; using an interactive Markov model

Peer Review reports

Original Submission
8 Jul 2015	Submitted	Original manuscript
13 Dec 2015	Reviewed	Reviewer Report - Benjamin Chung
14 Jan 2016	Author responded	Author comments - Emeka Udeh
Resubmission - Version 2
14 Jan 2016	Submitted	Manuscript version 2
15 Feb 2016	Author responded	Author comments - Emeka Udeh
Resubmission - Version 3
15 Feb 2016	Submitted	Manuscript version 3
17 Mar 2016	Author responded	Author comments - Emeka Udeh
Resubmission - Version 4
17 Mar 2016	Submitted	Manuscript version 4
Publishing
27 Jun 2016	Editorially accepted
7 Jul 2016	Article published	10.1186/s12885-016-2431-x

Back to article page